2019 Pediatric Residents Program
CARRA is a North American-based research organization of over 550 pediatric rheumatology investigators spanning more than 115 clinical practice sites. More than 95% of all board certified Pediatric Rheumatologists are members of CARRA. CARRA’s providers treat and study patients with all pediatric diseases such as JIA, lupus, dermatomyositis, localized scleroderma, systemic sclerosis, vasculitis, fibromyalgia, Kawasaki’s Disease, PFAPA, Sjögren’s Syndrome, CRMO, in addition to other auto-inflammatory diseases.
In the United States, 300,000 children are afflicted with arthritis and other rheumatic conditions, yet there are only (~360) pediatric rheumatologists across the country available to care for these children and half of children with rheumatic disease are seen by adult providers. To address the shortage of pediatric rheumatologists and to expose pediatric residents to the field of pediatric rheumatology, CARRA has created the Pediatric Residents Program.
The goals of the CARRA Pediatric Residents Program are to:
- Provide pediatric residents with access to the broad pediatric rheumatologic community through participation in CARRA’s Annual Scientific Meeting.
- Encourage interested pediatric residents to consider pediatric rheumatology as a subspecialty, thus improve patient access to pediatric rheumatologists.
To help achieve these goals, CARRA is providing funds to support pediatric residents’ attendance at the Annual CARRA Scientific Meeting at the Marriott Louisville Downtown in Louisville, KY from April 11-14, 2019. Awardees will be teamed with a CARRA member from another state/institution who will help guide their experience at the meeting.
To apply to the CARRA Pediatric Residents Program, including CARRA membership*, you will need to provide your contact information and a completed application. Your application must include the following items combined into one PDF document:
- Your CV
- A personal statement: This should consist of less than one page describing yourself, your career goals, and reasons you would like to attend the CARRA meeting.
- Letter of support from your current program director. The letter needs to state that you will be allowed to attend the entire CARRA meeting (April 11-14, 2019).
- Letter of support from a current CARRA Member and/or a pediatric rheumatology mentor.
*Submitting your application to CARRA’s Pediatric Residents Program includes applying for CARRA membership as a Trainee member. Membership is free for Trainees. Your Pediatric Residents Program application will serve as your membership application. You do not need to submit a separate membership application.
The application deadline has passed.
If you are selected to participate in CARRA’s Pediatric Residents Program, you will be eligible to receive reimbursement for the following travel/meeting related costs as outlines below:
Hotel Room at the Conference Hotel, 4/11-4/14 (shared)
Mileage and hotel parking (if driving to meeting location)
Taxi/shuttle to/from the Louisville airport
Airport Parking Fees
Airfare upgrade, insurance or change fees
Mileage to/from your local airport
Passport or travel visa fees
Expenses submitted without the original receipt
We will pair you with another resident to share a hotel room. You may stay in a private room; however, you will be responsible for the additional costs. CARRA will not charge a meeting registration fee and will provide group meals to conference attendees during the conference.
- Awardees are required to attend the full CARRA meeting and complete a meeting evaluation.
- Travel reimbursement will be provided following completion of the meeting.
- Scanned copies of all receipts are required for reimbursement.
- All reimbursement will be provided after the meeting.
CARRA’s mission is to conduct collaborative research to prevent, treat and cure pediatric rheumatic diseases and its largest research project is called the CARRA Registry. The CARRA Registry is a long-term observational study being conducted at over 70 research sites in the US and Canada. The CARRA Registry is studying the long-term safety of medications used to treat pediatric rheumatic diseases, and will follow at least 10,000 patients for 10 years. CARRA also participates in clinical trials and has a growing internal grant program, funded in large part by the Arthritis Foundation.
A world free of limitations from pediatric rheumatic diseases.
For any questions about CARRA’s Pediatric Residents Program or application, please contact CARRA’s Director of Administration, Brian Mondragón Jones (email@example.com).